Investing.com - Financial Markets Worldwide

Shanxi C&Y Pharmaceutical Group Co Ltd (300254)

Shenzhen
Currency in CNY
12.15
-0.20(-1.62%)
Closed·
300254 Scorecard
Full Analysis
Stock has taken a big hit over the last week
300254 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
12.0612.48
52 wk Range
7.4414.23
Key Statistics
Edit
Bid/Ask
12.14 / 12.15
Prev. Close
12.15
Open
12.38
Day's Range
12.06-12.48
52 wk Range
7.44-14.23
Volume
34.14M
Average Volume (3m)
30.98M
1-Year Change
40.78%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300254 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 10
Trading at a high earnings multiple
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Shanxi C&Y Pharmaceutical Group Co Ltd Company Profile

ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, respiratory drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, etc. The company’s product portfolio includes Fosfomycin tromethamine powder, Ebastine tablets, Tamsulosin hydrochloride sustained release capsules, Cinacalcet hydrochloride tablets, Apixaban tablets, Rivaroxaban tablets, Fluoxetine hydrochloride capsules, Ambroxol hydrochloride dispersible tablets, Montmorillonite powder, Varenicline tartrate tablets, Vitamin AD drops, and Baoling Yunbao oral liquid, as well as salt acid glucosamine raw material product. It also provides medical and health services and commercial services, such as medical diagnosis, gene preservation, and pregnancy environment testing services. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to ShanXi C&Y Pharmaceutical Group Co.,LTD. in September 2014. The company was founded in 2005 and is based in Datong, China.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
1196
Market
China

Compare 300254 to Peers and Sector

Metrics to compare
300254
Peers
Sector
Relationship
P/E Ratio
88.0x−13.7x−0.5x
PEG Ratio
−3.570.020.00
Price/Book
11.6x3.6x2.6x
Price / LTM Sales
3.6x4.5x3.3x
Upside (Analyst Target)
-−11.3%42.8%
Fair Value Upside
Unlock−9.1%6.5%Unlock

Earnings

Latest Release
Apr 18, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
181.74M / --
EPS Revisions
a
a
Unlock
Last 90 days

300254 Income Statement

FAQ

What Stock Exchange Does Shanxi C&Y Pharma Trade On?

Shanxi C&Y Pharma is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Shanxi C&Y Pharma?

The stock symbol for Shanxi C&Y Pharma is "300254."

What Is the Shanxi C&Y Pharma Market Cap?

As of today, Shanxi C&Y Pharma market cap is 3.02B.

What Is Shanxi C&Y Pharma's Earnings Per Share (TTM)?

The Shanxi C&Y Pharma EPS (TTM) is 0.14.

From a Technical Analysis Perspective, Is 300254 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Shanxi C&Y Pharma Stock Split?

Shanxi C&Y Pharma has split 2 times.

How Many Employees Does Shanxi C&Y Pharma Have?

Shanxi C&Y Pharma has 1196 employees.

What is the current trading status of Shanxi C&Y Pharma (300254)?

As of 07 Aug 2025, Shanxi C&Y Pharma (300254) is trading at a price of 12.15, with a previous close of 12.15. The stock has fluctuated within a day range of 12.06 to 12.48, while its 52-week range spans from 7.44 to 14.23.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.